Patient Selection Criteria and Management Guidelines for Outpatient Parenteral Antibiotic Therapy for Native Valve Infective Endocarditis
The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
Outpatient parenteral antibiotic therapy (OPAT) for infective endocarditis (IE) is being applied widely, despite the absence of controlled data that demonstrates that outcomes are equivalent to those with standard inpatient antibiotic therapy. We review existing OPAT guidelines, published data on the timing of complications from IE, and data on risk factors that can be used to predict complications. These data are used to propose more stringent criteria for patient selection and clinical management of OPAT for native valve IE. We recommend a conservative approach (inpatient or daily outpatient follow-up) during the critical phase (weeks 0-2 of treatment), when complications are most likely, and we recommend consideration of OPAT for the continuation phase (weeks 2-4 or 2-6 of treatment) when life-threatening complications are less likely.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Textbook of Cardiovascular Medicine
Topol, E. J. (1997) · Cited by 961
Daniel, W. G., Mügge, A., Martin, R. P., Lindert, O., Hausmann, D., Nonnast-Daniel, B., Laas, J., & Lichtlen, P. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241203 · Cited by 723 · cited 1×
“Transesophageal echocardiography has dramatically improved detection of perivalvular abscess, with a sensitivity of 87% and a specificity of 95%, compared with a sensitivity of 28% and a specificity of 99% for transthoracic echocardiography [80].”
BackgroundMügge, A., Daniel, W. G., Frank, G., & Lichtlen, P. R. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90104-6 · Cited by 654
Infective Endocarditis in the Antibiotic Era
Lerner, P. I., & Weinstein, L. (1966) · New England Journal of Medicine · doi:10.1056/nejm196601272740407 · Cited by 595 · cited 2×
“Heart failure due to valvular insufficiency is the leading complication of IE; it occurs in 15%–65% of cases [40, 52, 53, 63].”
BackgroundWilson, W. R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530210060032 · Cited by 492 · cited 2×
“According to the American Heart Association Guidelines for IE treatment [10], “inpatient therapy does not prevent.”
MethodNEUROLOGIC COMPLICATIONS OF BACTERIAL ENDOCARDITIS
PRUITT, A. A., RUBIN, R. H., KARCHMER, A. W., & DUNCAN, G. W. (1978) · Medicine · doi:10.1097/00005792-197807000-00004 · Cited by 419
Emboli in Infective Endocarditis: The Prognostic Value of Echocardiography
Steckelberg, J. M., Murphy, J. G., Ballard, D., Bailey, K., Tajik, A. J., Taliercio, C. P., Giuliani, E. R., & Wilson, W. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-8-635 · Cited by 411 · cited 2×
“to those of mitral valve vegetations [66].”
BackgroundTreatment of infective endocarditis: a 10-year comparative analysis.
Richardson, J. V., Karp, R. B., Kirklin, J. W., & Dismukes, W. E. (1978) · Circulation · doi:10.1161/01.cir.58.4.589 · Cited by 362 · cited 1×
“aureus is the pathogen most often associated with abscess [39, 77].”
BackgroundSanfilippo, A. J., Picard, M. H., Newell, J. B., Rosas, E., Davidoff, R., Thomas, J. D., & Weyman, A. E. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90535-h · Cited by 328
Arnett, E. N., & Roberts, W. C. (1976) · Circulation · doi:10.1161/01.cir.54.1.140 · Cited by 303 · cited 4×
“Other clinical features associated with periannular spread of IE have included new valvular regurgitation, pericarditis (usually a manifestation of ruptured valve ring abscess), new high-grade atrioventricular block, and a short fulminant clinical course [39].”
BackgroundInfluentialGARVEY, G. J., & NEU, H. C. (1978) · Medicine · doi:10.1097/00005792-197803000-00001 · Cited by 294 · cited 1×
“Heart failure due to valvular insufficiency is the leading complication of IE; it occurs in 15%–65% of cases [40, 52, 53, 63].”
BackgroundWilson, W. R. (1995) · JAMA · doi:10.1001/jama.274.21.1706 · Cited by 288
Infective Endocarditis at a Large Community Teaching Hospital, 1980–1990: A Review of 210 Episodes
WATANAKUNAKORN, C., & BURKERT, T. (1993) · Medicine · doi:10.1097/00005792-199303000-00003 · Cited by 255 · cited 1×
“Additional organisms that can cause high mortality rates include enterococci (15%–20% [32, 33, 43]), certain hemolytic streptococci (groups B, C, and G; 13%–20% [44]), and Enterobacteriaceae, Pseudomonas, and fungi (150% for each [45–48]).”
BackgroundInfluence of referral bias on the apparent clinical spectrum of infective endocarditis
Steckelberg, J. M., Rouse, M. S., Wilson, W. R., Melton, L. J., & Ilstrup, D. M. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90521-e · Cited by 206
Epidemiology of Bacterial Endocarditis in the Netherlands: I. Patient Characteristics
van der Meer, J. T. M. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400210087014 · Cited by 201 · cited 1×
“Additional organisms that can cause high mortality rates include enterococci (15%–20% [32, 33, 43]), certain hemolytic streptococci (groups B, C, and G; 13%–20% [44]), and Enterobacteriaceae, Pseudomonas, and fungi (150% for each [45–48]).”
BackgroundChoussat, R. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1240 · Cited by 196
Sexton, D. J., Tenenbaum, M. J., Wilson, W. R., Steckelberg, J. M., Tice, A. D., Gilbert, D., Dismukes, W., Drew, R. H., Durack, D. T., & Endocarditis Treatment Consortium Group (1998) · Clinical Infectious Diseases · doi:10.1086/515038 · Cited by 195 · cited 1×
“[28] 51 Unknown 8 (CTX monotherapy); 14.”
Neurologic complications of endocarditis: A 12‐year experience
Salgado, A. V., Furlan, A. J., Keys, T. F., Nichols, T. R., & Beck, G. J. (1989) · Neurology · doi:10.1212/wnl.39.2.173 · Cited by 191
Infective endocarditis: Clinical features in young and elderly patients
Terpening, M. S., Buggy, B. P., & Kauffman, C. A. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90890-4 · Cited by 188 · cited 1×
“Advanced age and comorbidity [36, 49, 50], aortic valve involvement [40, 51–53], and left-side [50, 54] and prosthetic valve IE disease [3] have all been associated with increased mortality rates.”
BackgroundStaphylococcus aureus endocarditis: clinical manifestations in addicts and nonaddicts.
Witchitz, S., Wolff, M., Fraisse, F., Jj, G., Rouveix, É., & Regnier, B. (1983) · PubMed · Cited by 169
Staphylococcus aureus Endocarditis: Clinical Manifestations in Addicts and Nonaddicts
CHAMBERS, H. F., KORZENIOWSKI, O. M., & SANDE, M. A. (1983) · Medicine · doi:10.1097/00005792-198305000-00004 · Cited by 153
Intravenous Antibiotic Therapy in an Outpatient Setting
Poretz, D. M. (1982) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1982.03330030042023 · Cited by 152
Francioli, P., Ruch, W., Stamboulian, D., & International Infective Endocarditis Study Group (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.6.1406 · Cited by 147
Heart Failure in Infective Endocarditis: Predisposing Factors, Course, and Treatment
Mills, J. L., Utley, J. R., & Utley, J. R. (1974) · CHEST Journal · doi:10.1378/chest.66.2.151 · Cited by 142 · cited 4×
“Heart failure due to valvular insufficiency is the leading complication of IE; it occurs in 15%–65% of cases [40, 52, 53, 63].”
BackgroundInfluential(2007) · Infective Endocarditis · doi:10.3109/9781420019834-12 · Cited by 134
Lutas, E. M., Roberts, R. B., Devereux, R. B., & Prieto, L. M. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90687-3 · Cited by 131 · cited 1×
“Embolic events are the second most common complication of IE; they occur in 22%–43% of cases [65, 66].”
BackgroundSome salient features of staphylococcus aureus endocarditis
Watanakunakorn, C., Tan, J. S., & Phair, J. (1973) · The American Journal of Medicine · doi:10.1016/0002-9343(73)90043-0 · Cited by 127
Aortic Insufficiency in Bacterial Endocarditis
GRIFFIN, F. M., JONES, G., & COBBS, C. G. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-1-23 · Cited by 127
Antibiotic Management of Outpatients with Endocarditis Due to Penicillin-Susceptible Streptococci
Stamboulian, D., Bonvehi, P., Arevalo, C., Bologna, R., Cassetti, I., Scilingo, V., & Efron, E. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.supplement_2.s160 · Cited by 127
The Complications of Infective Endocarditis: A Reappraisal in the 1980s
Mansur, A. J., Grinberg, M., da Luz, P. L., & Bellotti, G. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400240050008 · Cited by 125 · cited 1×
“In a recent series of 287 patients with IE, more than two-thirds had a serious complication during treatment [58].”
BackgroundFeasibility of outpatient self-administration of parenteral antibiotics.
Antoniskis, A., Bc, A., Ej, V. V., Jackson, J. M., & Dn, G. (1978) · PubMed Central · Cited by 123
Intravenous Antibiotic Therapy at Home
STIVER, H. G., TELFORD, G. O., MOSSEY, J. M., COTE, D. D., VAN MIDDLESWORTH, E. J., TROSKY, S. K., McKAY, N. L., & MOSSEY, W. L. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-5-690 · Cited by 119
Outpatient Parenteral Antimicrobial-Drug Therapy
Gilbert, D. N., Dworkin, R. J., Raber, S. R., & Leggett, J. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709183371207 · Cited by 117
Endocarditis-Associated Paravalvular Abscesses
Blumberg, E. A., Karalis, D. A., Chandrasekaran, K., Wahl, J. M., Vilaro, J., Covalesky, V. A., & Mintz, G. S. (1995) · Chest · doi:10.1378/chest.107.4.898 · Cited by 114
Rubinstein, E., & Lang, R. (1995) · European Heart Journal · doi:10.1093/eurheartj/16.suppl_b.84 · Cited by 114
Practice Guidelines for Community‐Based Parenteral Anti‐Infective Therapy
Williams, D. N., Rehm, S. J., Tice, A. D., Bradley, J. S., Kind, A. C., & Craig, W. A. (1997) · Clinical Infectious Diseases · doi:10.1086/515552 · Cited by 113
Home Intravenous Antibiotic Therapy: A Team Approach
Rehm, S. J., & WEINSTEIN, A. J. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-3-388 · Cited by 112
Home intravenous antibiotic therapy: A safe and effective alternative to inpatient care
Grayson, M. L., Silvers, J., & Turnidge, J. (1995) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1995.tb139878.x · Cited by 108
Enterococcal Endocarditis: A Comparison of Prosthetic and Native Valve Disease
Rice, L. B., Calderwood, S. B., Eliopoulos, G. M., Farber, B. F., & Karchmer, A. W. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.1.1 · Cited by 107 · cited 1×
“Additional organisms that can cause high mortality rates include enterococci (15%–20% [32, 33, 43]), certain hemolytic streptococci (groups B, C, and G; 13%–20% [44]), and Enterobacteriaceae, Pseudomonas, and fungi (150% for each [45–48]).”
BackgroundLife-Threatening Complications of Infective Endocarditis and Their Management
Weinstein, L. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.146.5.953 · Cited by 101 · cited 2×
“aureus infection [35, 37, 41], and acute disease [35, 37, 41].”
BackgroundSheldon, W. H., & Golden, A. (1951) · Circulation · doi:10.1161/01.cir.4.1.1 · Cited by 100
Infective Endocarditis Caused by β‐Hemolytic Streptococci
Baddour, L. M., & the Infectious Diseases Society of America's Emerging Infections Network (1998) · Clinical Infectious Diseases · doi:10.1086/516266 · Cited by 91
Management of Complications of Infective Endocarditis
Wilson, W. R., Giuliani, E. R., Danielson, G. K., & Geraci, J. E. (1982) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)18693-x · Cited by 90
Komshian, S. V., Tablan, O. C., Palutke, W., & Reyes, M. P. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.4.693 · Cited by 90
Quantification of regional myocardial perfusion by PET: Rationale and first clinical results
Schwaiger, M., & Hutchins, G. (1995) · European Heart Journal · doi:10.1093/eurheartj/16.suppl_j.84 · Cited by 87
Intravenous Antibiotic Therapy at Home
Kind, A. (1979) · Archives of Internal Medicine · doi:10.1001/archinte.1979.03630410023011 · Cited by 82
A critical appraisal of the quality of the management of infective endocarditis
Delahaye, F., Rial, M.-O., de Gévigney, G., Écochard, R., & Delaye, J. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00624-x · Cited by 81
Cardiac conduction abnormalities complicating native valve active infective endocarditis
DiNubile, M. J., Calderwood, S. B., Steinhaus, D. M., & Karchmer, A. W. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90384-x · Cited by 80 · cited 1×
“The sensitivity of electrocardiogram for perivalvular extension is only 27%–83% [70, 74, 78, 79], and the negative predictive value of a normal electrocardiogram is not known [70].”
BackgroundPredictive Risk Factors for Periannular Extension of Native Valve Endocarditis
Omari, B., Shapiro, S., Ginzton, L., Robertson, J. M., Ward, J., Nelson, R. J., & Bayer, A. S. (1989) · Chest · doi:10.1378/chest.96.6.1273 · Cited by 75
Staphylococcal Infective Endocarditis
Thompson, R. L. (1982) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)09759-9 · Cited by 69
Self-administration of intravenous antibiotics: an efficient, cost-effective home care program.
Stiver, H. G., Trosky, S. K., Cote, D. D., & Oruck, J. (1982) · PubMed · Cited by 66
Unfavourable Prognostic Factors in Staphylococcus Aureus Septicemia and Endocarditis
Julander, I. (1985) · Scandinavian Journal of Infectious Diseases · doi:10.3109/inf.1985.17.issue-2.09 · Cited by 63 · cited 2×
“Advanced age and comorbidity [36, 49, 50], aortic valve involvement [40, 51–53], and left-side [50, 54] and prosthetic valve IE disease [3] have all been associated with increased mortality rates.”
BackgroundPerivalvular Ectension of Infection in Patients with Infectious Endocarditis
Carpenter, J. L. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.1.127 · Cited by 61 · cited 2×
“The sensitivity of electrocardiogram for perivalvular extension is only 27%–83% [70, 74, 78, 79], and the negative predictive value of a normal electrocardiogram is not known [70].”
BackgroundPrognosis of native valve infective endocarditis: a review of 253 cases
Malquarti, V., Saradarian, W., Etienne, J., Milon, H., & Delahaye, J. P. (1984) · European Heart Journal · doi:10.1093/eurheartj/5.suppl_c.11 · Cited by 60 · cited 1×
“Persistent bacteremia, major emboli, mental status impairment or neurologic complications [50, 55, 56], and renal insufficiency [57] are all associated with adverse outcomes.”
BackgroundPerivalvular Abscesses Associated With Endocarditis
Aguado, J. M., González-Vílchez, F., Martín‐Durán, R., Arjona, R., & Tiffe, J. A. V. D. P. (1993) · CHEST Journal · doi:10.1378/chest.104.1.88 · Cited by 60 · cited 1×
“In another series of 30 patients with a discharge diagnosis of perivalvular abscess who had undergone surgery for IE, the mean time between initiation of antibiotic therapy and surgery was 23 days (range, 1–180 days) [75].”
BackgroundPaschalis, C., Pugsley, W., John, R., & Harrison, M. J. G. (1990) · European Neurology · doi:10.1159/000117317 · Cited by 59
Some Factors Affecting Prognosis in Bacterial Endocarditis
PEARCE, M. L., & GUZE, L. B. (1961) · Annals of Internal Medicine · doi:10.7326/0003-4819-55-2-270 · Cited by 58
Persistent Fever in Association with Infective Endocarditis
Blumberg, E. A., Robbins, N., Adimora, A. A., & Lowy, F. D. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.6.983 · Cited by 51
Duration of Fever during Treatment of Infective Endocarditis
Lederman, M. M., Sprague, L., Wallis, R. S., & Ellner, J. J. (1992) · MEDICINE · doi:10.1097/00005792-199201000-00005 · Cited by 44 · cited 1×
“150% had defervesced within 72 h of beginning therapy; 72% and 84% were afebrile by the end of weeks 1 and 2 of therapy, respectively (figure 1) [59].”
BackgroundSanson, J., Slodki, S. J., & Gruhn, J. G. (1963) · American Heart Journal · doi:10.1016/0002-8703(63)90260-6 · Cited by 39
OUTPATIENT INTRAVENOUS ANTIBIOTIC THERAPY FOR ENDOCARDITIS
Rehm, S. J. (1998) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70026-x · Cited by 37 · cited 7×
“Although the appropriate duration of IE therapy in the inpatient setting can be debated, the fact that home therapy for IE requires particular vigilance is not a matter of debate [11, 30].”
BackgroundMethodInfluentialTice, A. D. (1993) · Hospital Practice · doi:10.1080/21548331.1993.11442928 · Cited by 37
FEVER DURING TREATMENT OF INFECTIVE ENDOCARDITIS
Douglas, A., Moore-Gillon, J. C., & Eykyn, S. J. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91661-2 · Cited by 36 · cited 1×
“Fever that persists for more than 1 week while the patient is receiving therapy and recurrent fever have been associated with abscess [60].”
BackgroundThe complications of infective endocarditis. A reappraisal in the 1980s
Mansur, A. J. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.12.2428 · Cited by 34
Bayer, A. S., & Norman, D. C. (1990) · CHEST Journal · doi:10.1378/chest.98.1.200 · Cited by 31 · cited 1×
“Advanced age and comorbidity [36, 49, 50], aortic valve involvement [40, 51–53], and left-side [50, 54] and prosthetic valve IE disease [3] have all been associated with increased mortality rates.”
BackgroundOutpatient parenteral antibiotic therapy
Poretz, D. M. (1995) · International Journal of Antimicrobial Agents · doi:10.1016/0924-8579(94)00041-r · Cited by 31
Brown, R. B. (1993) · Hospital Practice · doi:10.1080/21548331.1993.11442929 · Cited by 26
Intravenous antibiotic therapy in an outpatient setting
Poretz, D. M. (1982) · JAMA · doi:10.1001/jama.248.3.336 · Cited by 25
The prevention and treatment of bacterial endocarditis
Pankey, G. A. (1979) · American Heart Journal · doi:10.1016/0002-8703(79)90326-0 · Cited by 22
Weisse, A. B., & Khan, M. Y. (1990) · Clinical Cardiology · doi:10.1002/clc.4960130507 · Cited by 22 · cited 1×
“The sensitivity of electrocardiogram for perivalvular extension is only 27%–83% [70, 74, 78, 79], and the negative predictive value of a normal electrocardiogram is not known [70].”
BackgroundPrognostic significance of valvular regurgitation in patients with infective endocarditis
Karalis, D. G., Blumberg, E. A., Vilaro, J. F., Covalesky, V. A., Wahl, J. M., Chandrasekaran, K., & Mintz, G. S. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80159-j · Cited by 20 · cited 1×
“However, echocardiographic evidence of valvular regurgitation does not necessarily predict future course of IE; similarly, its absence does not ensure a good prognosis [64].”
BackgroundGoldman, M. E., Fisher, E. A. A., Winters, S. C., Reichstein, R., Staville, K., Gorlin, R., & Fuster, V. (1995) · International Journal of Cardiology · doi:10.1016/0167-5273(95)02494-8 · Cited by 19 · cited 1×
“Heart failure due to valvular insufficiency is the leading complication of IE; it occurs in 15%–65% of cases [40, 52, 53, 63].”
BackgroundEndocarditis : medical and surgical management
Magilligan, D. J., & Quinn, E. L. (1986) · M. Dekker eBooks · Cited by 16
Home antibiotic therapy for streptococcal endocarditis: A call for a controlled trial
Colford, J. M., Corelli, R. L., Ganz, J. W., Guglielmo, B. J., & Jacobs, R. A. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90131-8 · Cited by 16 · cited 1×
“In a 1993 review [31], it was recommended that controlled trials be conducted to compare the outcomes of OPAT with those of inpatient parenteral antibiotic therapy before assuming that the 2 therapies have equal efficacy; such trials have not been published.”
BackgroundManagement of infective endocarditis
BMJ Publishing Group Ltd (2002) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2002.40426 · Cited by 15
Muhlestein, J. B. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00651-2 · Cited by 14
Intravenous antibiotic therapy at home
Kind, A. C. (1979) · Archives of Internal Medicine · doi:10.1001/archinte.139.4.413 · Cited by 14
Gram negative bacterial endocarditis
Hessen, M. T., & Abrutyn, E. (1992) · Cited by 12
Home intravenous antibiotic therapy
Durack, D. T., Karchmer, A. W., Blair, R., Wilson, A., Dismukes, W. E., Tice, A. D., Gilbert, D., Tenenbaum, M. J., Farber, B. F., & Täuber, M. G. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90133-a · Cited by 11
Durack, D. T. (1993) · Hospital Practice · doi:10.1080/21548331.1993.11442939 · Cited by 8 · cited 1×
“Patients with acute staphylococcal or enterococcal endocarditis and culture-negative IE have been deemed less suitable candidates for OPAT [29].”
Gentry, L. O., & Khoshdel, A. (1989) · Europe PMC (PubMed Central) · Cited by 6
Outpatient Parenteral Therapy of Serious Infections
Tice, A. D. (1998) · Oxford University Press eBooks · doi:10.1093/oso/9780195081039.003.0025 · Cited by 3
Research works printed but not linked: 18
- Wilson WR, 1982, Mayo Clin Proc, 57, 162
- Dismukes WE, 1981, Philadelphia: FA Davis, 189
- Scheld WM, 1995, New York: Churchill Livingstone, 740
- Patton J. Infective endocarditis: economic considerations. In: Kaye D, ed. Infective endocarditis. New York: Raven Press, 1992:413-422.
- Gentry LO, 1989, Tex Heart Inst J, 16, 250
- Antoniskis A, 1978, West J Med, 128, 203
- Rehm SJ, 1986, New York: Marcel Dekker, 117
- Stiver HG, 1982, Can Med Assoc J, 127, 207
- Francioli PB, 1993, Philadelphia: WB Saunders, 97
- Kunkel MJ, 1996, Chicago: Scientific American, 60
- Rehm SJ, 1998, Philadelphia: WB Saunders, 879
- 10.1001/archinte.152.9.1863 · doi:10.1001/archinte.152.9.1863 · Paper page
- Karchmer AW. Staphylococcal endocarditis. In: Kaye D, ed. Infective endocarditis. New York: Raven Press, 1992:225-249.
- Thompson RL, 1982, Mayo Clin Proc, 57, 106
- Karchmer AW, 1997, Philadelphia: WB Saunders, 1077
- Levinson ME. Response to therapy. In: Kaye D, ed. Infective endocarditis. Baltimore: University Park Press, 1976:185-199.
- Wilson WR, 1982, Mayo Clin Proc, 57, 155
- Schaff HV, 1986, New York: Marcel Dekker, 229
Cited by
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
“These findings may be influenced by confounding factors, in particular changes in the number of patients at risk of hospitalizations and healthcare-associated IE.”
InfluentialBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
“The timing for transition from inpatient antibiotic therapy to OPAT and patient exclusion criteria have been critically evaluated by Andrews and von Reyn.326 These guidelines are based on the local availability of medical care in the outpatient setting and risk factors and timing of potential adverse outcomes that wou…”
MethodGuidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis
Iversen, K., Ihlemann, N., Gill, S. U., Madsen, T., Elming, H., Jensen, K. T., Bruun, N. E., Høfsten, D. E., Fursted, K., Christensen, J. J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1808312 · Cited by 824
Metadata
- Authors
- Andrews, M., & von Reyn, C. F.
- Affiliations
- Dartmouth–Hitchcock Medical Center (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-07-15
- Volume
- 33
- Issue
- 2
- Pages
- 203-209
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2129274686
- Cited by
- 129
- References
- 82
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2023: 5 · 2022: 7 · 2021: 6 · 2020: 7 · 2019: 5 · 2018: 4 · 2017: 5 · 2016: 3 · 2015: 8 · 2014: 2 · 2013: 11 · 2012: 7
- FWCI
- 0.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Orthopedic Infections and Treatments
- Keywords
- outpatient parenteral antibiotic therapy, infective endocarditis, native valve endocarditis, patient selection criteria, treatment phases, risk factors, conservative treatment, antibiotic therapy
- MeSH terms
- Anti-Bacterial Agents, Endocarditis, Bacterial, Health Planning Guidelines, Heart Valves, Humans, Outpatients, Practice Guidelines as Topic, Patient Selection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.